GSE258991 enzalutamide DK1 [Tursiops] 5 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE258991_enzalutamide_DK1 [Tursiops]_5_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE258991_enzalutamide_DK1 [Tursiops]_5_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE258991_enzalutamide_DK1 [Tursiops]_5_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE258991_enzalutamide_DK1 [Tursiops]_5_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

carbonic anhydrase 2

Gene

MAGE family member A3

Gene

aquaporin 3 (Gill blood group)

Gene

heme oxygenase 1

Gene

secretory leukocyte peptidase inhibitor

Gene

argininosuccinate synthase 1

Gene

transmembrane 4 L six family member 1

Gene

MAGE family member A6

Gene

adhesion molecule with Ig like domain 2

Gene

carbonic anhydrase 12

  • Gene

    carbonic anhydrase 2


  • Gene

    MAGE family member A3


  • Gene

    aquaporin 3 (Gill blood group)


  • Gene

    heme oxygenase 1


  • Gene

    secretory leukocyte peptidase inhibitor


  • Gene

    argininosuccinate synthase 1


  • Gene

    transmembrane 4 L six family member 1


  • Gene

    MAGE family member A6


  • Gene

    adhesion molecule with Ig like domain 2


  • Gene

    carbonic anhydrase 12

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.